Result of AGM

GlaxoSmithKline PLC 21 May 2002 GlaxoSmithKline Annual General Meeting Poll Results GlaxoSmithKline is pleased to announce that the Second Annual General Meeting of shareholders of the Company was held at the Queen Elizabeth II Conference Centre on Monday 20th May 2002 at 2.30pm. All the resolutions proposed at the meeting were approved. The following table shows the votes cast for each Resolution: Resolution Total Votes For* Total Votes Against 1. Adoption of Financial Statements 3,477,877,370 178,630,017 2. Re-election of Paul Allaire as a Director 3,485,258,761 77,210,561 3. Re-election of Dr Michele Barzach as a Director 3,422,751,683 18,188,092 4. Re-appointment of Auditors 3,433,906,720 65,302,726 5. Remuneration of Auditors 3,612,287,622 8,510,665 6. Authorise donations to EU Political Organisations & 3,461,772,473 111,068,379 incur EU Political Expenditure 7. Disapplication of pre-emption rights** 3,677,163,156 37,908,042 8. Authority for the Company to purchase its own shares** 3,658,295,583 25,606,158 * Includes discretionary votes ** Indicates Special Resolutions requiring a 75% majority S M Bicknell Company Secretary 21st May 2002 This information is provided by RNS The company news service from the London Stock Exchange KOBKDFPB

Companies

GSK (GSK)
UK 100

Latest directors dealings